Clinical Trial

Starlight Cardiovascular Lifeline Ductus Arteriosus Stent IDE Study

Recruiting
View on ClinicalTrials.gov →
Summary
Starlight Cardiovascular, Inc. is sponsoring a prospective, multi-center, study to evaluate safety and effectiveness of the Lifeline Ductus Arteriosus Stent System. The study device is a stent that is designed to maintain patency of the Ductus Arteriosus for children who need blood flow through that part of the heart.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-08-03; most recent amendment 2026-04-29.
Status change: Not Yet Recruiting → Recruiting 2026-02-25
Trial Details
NCT Number NCT07114718
Lead Sponsor Starlight Cardiovascular Inc
Collaborators: National Institutes of Health (NIH)
Conditions Congenital Heart Disease, Congenital Heart Disease (CHD)
Enrollment 35 participants
Start Date 2026-01-16
Primary Completion 2027-10 (estimated)
Study Completion 2028-04 (estimated)
Updated on ClinicalTrials.gov 2026-05-01